TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from WuXi XDC Cayman, Inc. ( (HK:2268) ) is now available.
WuXi XDC Cayman Inc. has announced its Annual General Meeting scheduled for June 27, 2025, in Wuxi City, China. The meeting will address several key agenda items, including the reception of audited financial statements, re-election and appointment of directors, and authorization of directors’ remuneration. Additionally, the company seeks approval for a mandate to issue and allot shares, reflecting its strategic focus on expanding its operational capabilities and enhancing shareholder value.
The most recent analyst rating on (HK:2268) stock is a Hold with a HK$28.20 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.
More about WuXi XDC Cayman, Inc.
WuXi XDC Cayman Inc. is a company incorporated in the Cayman Islands, focusing on biotechnology services. It operates within the pharmaceutical and biotech industry, providing specialized solutions to support drug development and manufacturing.
Average Trading Volume: 8,756,653
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$44.38B
See more data about 2268 stock on TipRanks’ Stock Analysis page.